malondialdehyde has been researched along with punicalagin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Abukhalil, MH; Ahmeda, AF; Al-Swailmi, FK; Aladaileh, SH; Mahmoud, AM | 1 |
Abukhalil, MH; Al-Khawalde, AAA; Aladaileh, SH; Alanezi, AA; Alaryani, FS; Alasmari, F; Aldal'in, HK; Alfwuaires, MA; Algefare, AI; Althunibat, OY; Jghef, MM; Karimulla, S | 1 |
2 other study(ies) available for malondialdehyde and punicalagin
Article | Year |
---|---|
Punicalagin prevents cisplatin-induced nephrotoxicity by attenuating oxidative stress, inflammatory response, and apoptosis in rats.
Topics: Acute Kidney Injury; Animals; Apoptosis; Blood Urea Nitrogen; Catalase; Cisplatin; Glutathione; Hydrolyzable Tannins; Inflammation; Kidney; Male; Malondialdehyde; Nitric Oxide; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase | 2021 |
Punicalagin Protects against the Development of Methotrexate-Induced Hepatotoxicity in Mice via Activating Nrf2 Signaling and Decreasing Oxidative Stress, Inflammation, and Cell Death.
Topics: Animals; Antioxidants; bcl-2-Associated X Protein; Caspase 3; Catalase; Cell Death; Chemical and Drug Induced Liver Injury; Glutathione; Inflammation; Interleukin-6; Liver; Malondialdehyde; Methotrexate; Mice; NF-E2-Related Factor 2; NF-kappa B; Nitric Oxide; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Superoxide Dismutase; Transaminases; Tumor Necrosis Factor-alpha | 2022 |